Endo Launches Generic of Fortesta Gel, Teva Launches Generic of Baraclude

In recent generic drug developments, Endo International launched an authorized generic version of the testosterone gel Fortesta and Teva Pharmaceutical Industries launched a generic version of the hepatitis B drug Baraclude.

Endo International Plc Sept. 8 said it has launched the first generic 2 percent topical testosterone gel, an authorized version of its Fortesta Gel.

Fortesta and the authorized generic version are the only 2 percent testosterone gels approved by the Food and Drug Administration to treat adult males diagnosed with hypogonadism, the company said.

The authorized generic product, distributed by Qualitest and promoted by Endo Pharmaceuticals Inc., now is ...